Myda Advisors LLC Guardant Health, Inc. Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $266,156 - $429,000	-4,400 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$59.04 - $88.81 $2.82 Million - $4.25 Million	-47,800 Reduced 91.57%	4,400 $306,000
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $2.39 Million - $3.33 Million	40,200 Added 335.0%	52,200 $4.08 Million
Q1 2019 May 13, 2019	BUY	$34.3 - $97.98 $411,599 - $1.18 Million	12,000 New	12,000 $920,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.62B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.